Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Moldvay

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Scientific Reports|January 5, 2017
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasisZoltan Lohinai, Thomas Klikovits, Judit Moldvay, et al.
Peerj|August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancerZoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.
Molecular Oncology|June 8, 2020
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distributionDavid Dora, Christopher Rivard, Hui Yu, et al.
Scientific Data|March 14, 2026
A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division AnalysisZsanett Zsofia Ivan, Dominik Hirling, Istvan Grexa, et al.
Virchows Archiv : an International Journal of Pathology|January 20, 2017
Breast carcinoma subtypes show different patterns of metastatic behaviorIstván Artúr Molnár, Béla Ákos Molnár, Laura Vízkeleti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2015
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung AdenocarcinomaZoltan Lohinai, Mir Alireza Hoda, Katalin Fabian, et al.
The Journal of Molecular Diagnostics : JMD|February 9, 2008
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistryFerenc Pinter, Judit Papay, Andrea Almasi, et al.
Magyar Onkologia|September 23, 2020
[Novel approaches to the epidemiology of lung cancer in Hungary]Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Frontiers in Oncology|November 12, 2019
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From HungaryKrisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Translational Lung Cancer Research|March 15, 2021
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter studyBalazs Gieszer, Zsolt Megyesfalvi, Viktoria Dulai, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Scientific Reports|January 5, 2017
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasisZoltan Lohinai, Thomas Klikovits, Judit Moldvay, et al.
Peerj|August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancerZoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.
Molecular Oncology|June 8, 2020
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distributionDavid Dora, Christopher Rivard, Hui Yu, et al.
Scientific Data|March 14, 2026
A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division AnalysisZsanett Zsofia Ivan, Dominik Hirling, Istvan Grexa, et al.
Virchows Archiv : an International Journal of Pathology|January 20, 2017
Breast carcinoma subtypes show different patterns of metastatic behaviorIstván Artúr Molnár, Béla Ákos Molnár, Laura Vízkeleti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2015
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung AdenocarcinomaZoltan Lohinai, Mir Alireza Hoda, Katalin Fabian, et al.
The Journal of Molecular Diagnostics : JMD|February 9, 2008
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistryFerenc Pinter, Judit Papay, Andrea Almasi, et al.
Magyar Onkologia|September 23, 2020
[Novel approaches to the epidemiology of lung cancer in Hungary]Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Frontiers in Oncology|November 12, 2019
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From HungaryKrisztina Bogos, Zoltán Kiss, Gabriella Gálffy, et al.
Translational Lung Cancer Research|March 15, 2021
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter studyBalazs Gieszer, Zsolt Megyesfalvi, Viktoria Dulai, et al.
Pageof 11